Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 18 de 18
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Biochemistry (Mosc) ; 89(6): 1122-1132, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38981705

RÉSUMÉ

Integration of the DNA copy of HIV-1 genome into the cellular genome results in series of damages, repair of which is critical for successful replication of the virus. We have previously demonstrated that the ATM and DNA-PK kinases, normally responsible for repairing double-strand breaks in the cellular DNA, are required to initiate the HIV-1 DNA postintegrational repair, even though integration does not result in DNA double-strand breaks. In this study, we analyzed changes in phosphorylation status of ATM (pSer1981), DNA-PK (pSer2056), and their related kinase ATR (pSer428), as well as their targets: Chk1 (pSer345), Chk2 (pThr68), H2AX (pSer139), and p53 (pSer15) during the HIV-1 DNA postintegrational repair. We have shown that ATM and DNA-PK, but not ATR, undergo autophosphorylation during postintegrational DNA repair and phosphorylate their target proteins Chk2 and H2AX. These data indicate common signaling mechanisms between the double-strand DNA break repair and postintegrational repair of HIV-1 DNA.


Sujet(s)
Protéines mutées dans l'ataxie-télangiectasie , Réparation de l'ADN , DNA-activated protein kinase , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Protéines mutées dans l'ataxie-télangiectasie/métabolisme , Humains , Phosphorylation , DNA-activated protein kinase/métabolisme , Checkpoint kinase 2/métabolisme , Checkpoint kinase 2/génétique , Intégration virale , Histone/métabolisme , Cassures double-brin de l'ADN
2.
Data Brief ; 54: 110526, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38799714

RÉSUMÉ

Onchidoris muricata is a widespread shell-less species of nudibranch molluscs, which has unique for Gastropoda skeletal elements - subepidermal calcite spicules. The general and fine morphology of the spicules, as well as their maturation process in ontogenesis, have been studied in detail by authors. The uniqueness of spicules lies in their intracellular formation and location under the ectodermal epithelium, which is more typical for deuterostomes. We present O. muricata as a potentially new model species for studying calcification of intracellular protein structure. A total of 96 individuals were collected in the Kandalaksha Bay of the White Sea, both manually and by scuba diving. All individuals were divided into three groups based on morphological characteristics such as specimens' size, spicule condition etc. This division suggests the existence of three stages in postembryonic ontogenesis of O. muricata reflecting the maturation of the spicule complex. Total RNA samples were isolated from three size groups of molluscs in three biological replicates. Libraries were prepared from the polyadenylated RNA fraction and sequenced at NovaSeq6000 (Illumina), yielding a total of 112.8 Gb of 150 bp paired-end reads, corresponding to almost 1,000-fold coverage of the transcriptome. Representative transcriptome assembled de novo with Trinity. In addition to obtaining the transcriptome sequences of O. muricata, differential expression analysis was also performed for these three size groups. This allows us to trace the dynamics of molecular and biological processes during the life of a mollusc. The obtained data can then be used as a reference transcriptome for closely related species, to study specific expressed genes, to identify various unique sequences, including protein-coding ones, to understand biological processes, including biomineralization and much more.

3.
Int J Mol Sci ; 24(24)2023 Dec 11.
Article de Anglais | MEDLINE | ID: mdl-38139188

RÉSUMÉ

Integration of HIV-1 genomic cDNA results in the formation of single-strand breaks in cellular DNA, which must be repaired for efficient viral replication. Post-integration DNA repair mainly depends on the formation of the HIV-1 integrase complex with the Ku70 protein, which promotes DNA-PK assembly at sites of integration and its activation. Here, we have developed a first-class inhibitor of the integrase-Ku70 complex formation that inhibits HIV-1 replication in cell culture by acting at the stage of post-integration DNA repair. This inhibitor, named s17, does not affect the main cellular function of Ku70, namely its participation in the repair of double-strand DNA breaks through the non-homologous end-joining pathway. Using a molecular dynamics approach, we have constructed a model for the interaction of s17 with Ku70. According to this model, the interaction of two phenyl radicals of s17 with the L76 residue of Ku70 is important for this interaction. The requirement of two phenyl radicals in the structure of s17 for its inhibitory properties was confirmed using a set of s17 derivatives. We propose to stimulate compounds that inhibit post-integration repair by disrupting the integrase binding to Ku70 KuINins.


Sujet(s)
VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Autoantigène Ku/génétique , Réparation de l'ADN , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , ADN , Integrases/métabolisme , Réparation de l'ADN par jonction d'extrémités
4.
Int J Mol Sci ; 24(3)2023 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-36769109

RÉSUMÉ

The integration of a DNA copy of an HIV-1 RNA genome into the host genome, carried out by the viral enzyme integrase, results in the formation of single-stranded gaps in cellular DNA that must be repaired. Here, we have analyzed the involvement of the PI3K kinases, ATM, ATR, and DNA-PKcs, which are important players in the DNA damage response (DDR) in HIV-1 post-integrational DNA repair (PIR). The participation of the DNA-PK complex in HIV-1 PIR has been previously shown, and the formation of a complex between the viral integrase and the DNA-PK subunit, Ku70, has been found to be crucial for efficient PIR. Now, we have shown that the inhibition of both DNA-PKcs and ATM, but not ATR, significantly reduces PIR efficiency. The activation of both kinases is a sequential process, where one kinase, being activated, activates the other, and it occurs simultaneously with the integration of viral DNA. This fact suggests that the activation of both kinases triggers PIR. Most interestingly, the activation of not only DNA-PKcs, but also ATM depends on the complex formation between integrase and Ku70. The elucidation of the interactions between viruses and DDR is important both for understanding the modulation of host cell functions by these pathogens and for developing new approaches to combat viral infections.


Sujet(s)
VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Protéines mutées dans l'ataxie-télangiectasie/génétique , Protéines mutées dans l'ataxie-télangiectasie/métabolisme , DNA-activated protein kinase/génétique , Réparation de l'ADN , Altération de l'ADN , ADN viral/génétique , Integrases/génétique
5.
Int J Mol Sci ; 23(20)2022 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-36293197

RÉSUMÉ

RNA viruses, in pursuit of genome miniaturization, tend to employ cellular proteins to facilitate their replication. HIV-1, one of the most well-studied retroviruses, is not an exception. There is numerous evidence that the exploitation of cellular machinery relies on nucleic acid-protein and protein-protein interactions. Apart from Vpr, Vif, and Nef proteins that are known to regulate cellular functioning via interaction with cell components, another viral protein, integrase, appears to be crucial for proper virus-cell dialog at different stages of the viral life cycle. The goal of this review is to summarize and systematize existing data on known cellular partners of HIV-1 integrase and their role in the HIV-1 life cycle.


Sujet(s)
Intégrase du VIH , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Acides nucléiques , Réplication virale , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Protéines virales
6.
Biochimie ; 199: 139-149, 2022 Aug.
Article de Anglais | MEDLINE | ID: mdl-35430316

RÉSUMÉ

DNA-dependent protein kinase (DNA-PK) is a key player in the NHEJ repair pathway. DNA-PK and its subunits, Ku70, Ku80, and catalytic subunit (DNA-PKcs), also participate in other cellular processes; however, there are still no systemic data on the effect of depletion of Ku70, Ku80 and DNA-PKcs on cell functions in the same cell line. Here, we analyzed transcriptome changes in HEK 293T cells after depletion of each DNA-PK subunit. Depletion of various DNA-PK subunits resulted in dramatic differences in the number of differentially expressed genes: only 7 genes changed more than 2-fold in DNA-PKcs-deficient cells, 29 genes in Ku80-deficient, 219 genes in Ku70-deficient. All DNA-PKcs-dependent genes were stress-related and depended on both Ku70 and Ku80. Two-thirds of Ku80-dependent genes were also differentially expressed in the Ku70-deficient line. Most Ku70-dependent genes were altered exclusively in Ku70-depleted cells, indicating that Ku70 is involved in the regulation of more processes than Ku80. GO enrichment analysis showed the effect of Ku70 knockdown on cell adhesion and matrix organization, protein degradation, cell proliferation, and differentiation. Depletion of Ku70, but not Ku80, provided greater cell motility and disassembly of cell-cell contacts. These data clearly indicate that Ku70 is more functionally important for the cell life than DNA-PKcs and even Ku80.


Sujet(s)
Antigènes nucléaires , DNA-activated protein kinase , Antigènes nucléaires/génétique , Antigènes nucléaires/métabolisme , ADN/métabolisme , Réparation de l'ADN , DNA-activated protein kinase/génétique , DNA-activated protein kinase/métabolisme , Protéines de liaison à l'ADN/métabolisme , Analyse de profil d'expression de gènes , Cellules HEK293 , Humains , Autoantigène Ku/génétique , Autoantigène Ku/métabolisme , Protéines nucléaires/métabolisme
7.
Front Mol Biosci ; 9: 753318, 2022.
Article de Anglais | MEDLINE | ID: mdl-35359606

RÉSUMÉ

Sorafenib is a tyrosine kinase inhibitory drug with multiple molecular specificities that is approved for clinical use in second-line treatments of metastatic and advanced renal cell carcinomas (RCCs). However, only 10-40% of RCC patients respond on sorafenib-containing therapies, and personalization of its prescription may help in finding an adequate balance of clinical efficiency, cost-effectiveness, and side effects. We investigated whether expression levels of known molecular targets of sorafenib in RCC can serve as prognostic biomarker of treatment response. We used Illumina microarrays to profile RNA expression in pre-treatment formalin-fixed paraffin-embedded (FFPE) samples of 22 metastatic or advanced RCC cases with known responses on next-line sorafenib monotherapy. Among them, nine patients showed partial response (PR), three patients-stable disease (SD), and 10 patients-progressive disease (PD) according to Response Evaluation Criteria In Solid Tumors (RECIST) criteria. We then classified PR + SD patients as "responders" and PD patients as "poor responders". We found that gene signature including eight sorafenib target genes was congruent with the drug response characteristics and enabled high-quality separation of the responders and poor responders [area under a receiver operating characteristic curve (AUC) 0.89]. We validated these findings on another set of 13 experimental annotated FFPE RCC samples (for 2 PR, 1 SD, and 10 PD patients) that were profiled by RNA sequencing and observed AUC 0.97 for 8-gene signature as the response classifier. We further validated these results in a series of qRT-PCR experiments on the third experimental set of 12 annotated RCC biosamples (for 4 PR, 3 SD, and 5 PD patients), where 8-gene signature showed AUC 0.83.

8.
Int J Mol Sci ; 23(6)2022 Mar 08.
Article de Anglais | MEDLINE | ID: mdl-35328329

RÉSUMÉ

The interaction of HIV-1 integrase and the cellular Ku70 protein is necessary for HIV replication due to its positive effect on post-integration DNA repair. We have previously described in detail the Ku70 binding site within integrase. However, the integrase binding site in Ku70 remained poorly characterized. Here, using a peptide fishing assay and site-directed mutagenesis, we have identified residues I72, S73, and I76 of Ku70 as key for integrase binding. The molecular dynamics studies have revealed a possible way for IN to bind to Ku70, which is consistent with experimental data. According to this model, residues I72 and I76 of Ku70 form a "leucine zipper" with integrase residues, and, therefore, their concealment by low-molecular-weight compounds should impede the Ku70 interaction with integrase. We have identified such compounds by molecular docking and have confirmed their capacity to inhibit the formation of the integrase complex with Ku70. Our data demonstrate that the site of IN binding within Ku70 identified in the present work may be used for further search for inhibitors of the integrase binding to Ku70.


Sujet(s)
Intégrase du VIH , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Intégrase du VIH/composition chimique , Autoantigène Ku/métabolisme , Simulation de docking moléculaire , Liaison aux protéines
9.
Data Brief ; 39: 107596, 2021 Dec.
Article de Anglais | MEDLINE | ID: mdl-34849385

RÉSUMÉ

DNA-PK is a heterotrimeric complex that consists of Ku70 (XRCC6), Ku80 (XRCC5) and DNA-PKcs (PRKDC) subunits. The complex is a major player in the repair of DNA double strand break (DSB) via the non-homologous end joining (NHEJ) pathway. This process requires all DNA-PK subunits, since Ku70/Ku80 heterodimer firstly binds to DNA ends at DSB and then recruits DNA-PKcs. Recruitment of the DNA-PKcs subunit to DSB leads to phosphorylation events near DSB and recruitment of other NHEJ-related proteins that restore DNA integrity. However, today a lot of evidence demonstrates participation of the DNA-PK components in other cellular processes, e.g. telomere length maintenance, transcription, metabolism regulation, cytosolic DNA sensing, apoptosis, cellular movement and adhesion. It is important to note that not all the subunits of the DNA-PK complex are necessary for these processes, and the largest number of independent functions has been shown for the Ku70/Ku80 heterodimer and especially the Ku70 subunit. To better understand the role of each DNA-PK subunit in the cell life, we have analyzed transcriptome changes in HEK293T cells depleted of Ku70, Ku80 or DNA-PKcs using NGS-sequencing. Here, for the first time, we present the data obtained from the transcriptome analysis.

10.
Biomolecules ; 10(9)2020 08 25.
Article de Anglais | MEDLINE | ID: mdl-32854330

RÉSUMÉ

The search for compounds that can inhibit the interaction of certain viral proteins with their cellular partners is a promising trend in the development of antiviral drugs. We have previously shown that binding of HIV-1 integrase with human Ku70 protein is essential for viral replication. Here, we present a novel, cheap, and fast assay to search for inhibitors of these proteins' binding based on the usage of genetically encoded fluorescent tags linked to both integrase and Ku70. Using this approach, we have elucidated structure-activity relationships for a set of oligonucleotide conjugates with eosin and shown that their inhibitory activity is primarily achieved through interactions between the conjugate nucleic bases and integrase. Molecular modeling of HIV-1 integrase in complex with the conjugates suggests that they can shield E212/L213 residues in integrase, which are crucial for its efficient binding to Ku70, in a length-dependent manner. Using the developed system, we have found the 11-mer phosphorothioate bearing 3'-end eosin-Y to be the most efficient inhibitor among the tested conjugates.


Sujet(s)
Inhibiteurs de l'intégrase du VIH/composition chimique , Inhibiteurs de l'intégrase du VIH/pharmacologie , Intégrase du VIH/effets des médicaments et des substances chimiques , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Autoantigène Ku/métabolisme , Oligonucléotides phosphorothioates/composition chimique , Oligonucléotides phosphorothioates/pharmacologie , Éosine jaunâtre/composition chimique , Colorants fluorescents/composition chimique , Intégrase du VIH/composition chimique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Tests de criblage à haut débit , Humains , Autoantigène Ku/composition chimique , Tests de sensibilité microbienne , Modèles moléculaires , Simulation de docking moléculaire , Motifs et domaines d'intéraction protéique/effets des médicaments et des substances chimiques , Protéines recombinantes/composition chimique , Protéines recombinantes/métabolisme , Relation structure-activité , Réplication virale/effets des médicaments et des substances chimiques
11.
Cells ; 9(8)2020 08 16.
Article de Anglais | MEDLINE | ID: mdl-32824372

RÉSUMÉ

The DNA dependent protein kinase (DNA-PK) is a trimeric nuclear complex consisting of a large protein kinase and the Ku heterodimer. The kinase activity of DNA-PK is required for efficient repair of DNA double-strand breaks (DSB) by non-homologous end joining (NHEJ). We also showed that the kinase activity of DNA-PK is essential for post-integrational DNA repair in the case of HIV-1 infection. Besides, DNA-PK is known to participate in such cellular processes as protection of mammalian telomeres, transcription, and some others where the need for its phosphorylating activity is not clearly elucidated. We carried out a systematic search and analysis of DNA-PK targets described in the literature and identified 67 unique DNA-PK targets phosphorylated in response to various in vitro and/or in vivo stimuli. A functional enrichment analysis of DNA-PK targets and determination of protein-protein associations among them were performed. For 27 proteins from these 67 DNA-PK targets, their participation in the HIV-1 life cycle was demonstrated. This information may be useful for studying the functioning of DNA-PK in various cellular processes, as well as in various stages of HIV-1 replication.


Sujet(s)
DNA-activated protein kinase/génétique , DNA-activated protein kinase/métabolisme , Infections à VIH/enzymologie , Infections à VIH/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/métabolisme , Réplication virale , Animaux , Cassures double-brin de l'ADN , Réparation de l'ADN par jonction d'extrémités/génétique , ADN viral/génétique , ADN viral/métabolisme , Protéines de liaison à l'ADN/métabolisme , Infections à VIH/virologie , Humains , Autoantigène Ku/métabolisme , Phosphorylation
12.
Retrovirology ; 16(1): 30, 2019 11 06.
Article de Anglais | MEDLINE | ID: mdl-31690330

RÉSUMÉ

BACKGROUND: HIV-1 integration results in genomic DNA gaps that are repaired by cellular DNA repair pathways. This step of the lentiviral life cycle remains poorly understood despite its crucial importance for successful replication. We and others reported that Ku70 protein of the non-homologous end joining pathway (NHEJ) directly binds HIV-1 integrase (IN). Here, we studied the importance of this interaction for post-integrational gap repair and the recruitment of NHEJ factors in this process. RESULTS: We engineered HIV-based pseudovirus with mutant IN defective in Ku70 binding and generated heterozygous Ku70, Ku80 and DNA-PKcs human knockout (KO) cells using CRISPR/Cas9. KO of either of these proteins or inhibition of DNA-PKcs catalytic activity substantially decreased the infectivity of HIV-1 with native IN but not with the mutant one. We used a recently developed qPCR assay for the measurement of gap repair efficiency to show that HIV-1 with mutant IN was defective in DNA post-integrational repair, whereas the wild type virus displayed such a defect only when NHEJ system was disrupted in any way. This effect was present in CRISPR/Cas9 modified 293T cells, in Jurkat and CEM lymphoid lines and in primary human PBMCs. CONCLUSIONS: Our data provide evidence that IN recruits DNA-PK to the site of HIV-1 post-integrational repair due to Ku70 binding-a novel finding that explains the involvement of DNA-PK despite the absence of free double stranded DNA breaks. In addition, our data clearly indicate the importance of interactions between HIV-1 IN and Ku70 in HIV-1 replication at the post-integrational repair step.


Sujet(s)
Réparation de l'ADN par jonction d'extrémités , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Autoantigène Ku/métabolisme , Cassures double-brin de l'ADN , Intégrase du VIH/génétique , Interactions hôte-microbes , Humains , Autoantigène Ku/génétique , Voies et réseaux métaboliques
13.
J Virol Methods ; 262: 12-19, 2018 12.
Article de Anglais | MEDLINE | ID: mdl-30219707

RÉSUMÉ

The post-integrational gap repair is a critical and poorly studied stage of the lentiviral life cycle. It might be performed by various cellular DNA repair pathways but the exact mechanism of the repair process has not yet been described. One of the reasons for that is the lack of a functional quantitative assay that could precisely measure the amount of integrated viral DNA that has completed the post-integrational gap repair stage. Here, we present an approach that is based on a widely used Alu-specific PCR for the estimation of integrated viral DNA but includes several steps that allow discrimination between integrated-repaired and integrated-unrepaired viral DNA forms. We used the approach for the estimation of the kinetics of gap repair in a viral vector system and showed that the gap repair process starts at 17 h post infection and lasts 10 more hours. We also showed that the addition of Nu7441 - a small molecule inhibitor of DNA-breaks sensor kinase in the non-homologous end joining DNA repair pathway - specifically inhibits the gap repair process while having no influence on the integration itself.


Sujet(s)
Réparation de l'ADN , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Réaction de polymérisation en chaîne/méthodes , Intégration virale , Réplication virale , 4H-1-Benzopyran-4-ones/pharmacologie , Réplication de l'ADN , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Morpholines/pharmacologie
14.
Sci Rep ; 7(1): 5649, 2017 07 17.
Article de Anglais | MEDLINE | ID: mdl-28717247

RÉSUMÉ

Human Ku70/Ku80 protein is known to influence HIV-1 replication. One of the possible reasons may be the protection of integrase from proteasomal degradation by Ku70 subunit. We demonstrated that recombinant HIV-1 integrase and Ku70 form a stable complex, while no interaction of Ku70 with integrase from prototype foamy virus was observed. By analyzing protein subdomains we determined two binding sites in the structure of both Ku70 and integrase: the 51-160 a.a. region of integrase interacts with residues 251-438 of Ku70, whereas Ku70 N-terminal domain (1-250 a.a.) contacts an α6-helix in the 200-220 a.a. integrase region. Single substitutions within integrase (E212A or L213A) block the interaction with Ku70 thus indicating that the binding site formed by the 200-220 a.a. integrase region is crucial for complex formation. E212A/L213A substitutions decreased the integrase capacity to bind Ku70 in HEK293T cells. A conjugate of 2'-ОMe-GGUUUUUGUGU oligonucleotide with eosin is shown by molecular modeling to shield integrase residues E212/L213 and is effective in blocking complex formation of Ku70 with integrase what makes the complex between α6-helix and Ku70(1-250) a possible target for drug development.


Sujet(s)
Intégrase du VIH/composition chimique , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Autoantigène Ku/composition chimique , Autoantigène Ku/métabolisme , Substitution d'acide aminé , Sites de fixation , Domaine catalytique , Systèmes de délivrance de médicaments , Cellules HEK293 , Intégrase du VIH/génétique , Humains , Modèles moléculaires , Simulation de docking moléculaire , Mutagenèse dirigée , Liaison aux protéines , Domaines protéiques , Structure secondaire des protéines , Protéines recombinantes/composition chimique , Protéines recombinantes/métabolisme
15.
Biochimie ; 132: 85-93, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-27825805

RÉSUMÉ

Human protein Ku usually functions in the cell as a complex of two subunits, Ku70 and Ku80. The Ku heterodimer plays a key role in the non-homologous end joining DNA repair pathway by specifically recognizing the DNA ends at the site of the lesion. The binding of the Ku heterodimer to DNA has been well-studied, and its interactions with RNA have been also described. However, Ku70 subunit is known to have independent DNA binding capability, which is less characterized. RNA binding properties of Ku70 have not been yet specially studied. We have prepared recombinant full-length Ku70 and a set of its truncated mutants in E. coli, and studied their interactions with nucleic acids of various structures: linear single- and double-stranded DNA and RNA, as well as closed circular DNA and hairpin RNA. Ku70 has demonstrated a high affinity binding to double stranded DNA and hairpin RNA with a certain structure only. Interestingly, in contrast to the Ku heterodimer, Ku70 is found to interact with closed circular DNA. We also show for the first time that Ku70 employs two different sites for DNA and RNA binding. The double-stranded DNA is recognized by the C-terminal part of Ku70 including SAP domain as it has been earlier demonstrated, whereas hairpin RNA binding is provided by amino acids 251-438.


Sujet(s)
ADN circulaire/métabolisme , ADN/métabolisme , Autoantigène Ku/métabolisme , ARN/métabolisme , Séquence nucléotidique , Sites de fixation/génétique , Fixation compétitive , Technique de Western , ADN/composition chimique , ADN/génétique , ADN circulaire/composition chimique , ADN circulaire/génétique , Humains , Cinétique , Autoantigène Ku/composition chimique , Autoantigène Ku/génétique , Conformation d'acide nucléique , Motifs nucléotidiques/génétique , Liaison aux protéines , Domaines protéiques , ARN/composition chimique , ARN/génétique , Protéines recombinantes/composition chimique , Protéines recombinantes/métabolisme , Similitude de séquences d'acides nucléiques
16.
Eur J Med Chem ; 73: 73-82, 2014 Feb 12.
Article de Anglais | MEDLINE | ID: mdl-24378711

RÉSUMÉ

The integration of viral DNA into the cell genome is one of the key steps in the replication cycle of human immunodeficiency virus type 1 (HIV-1). Therefore, the viral enzyme integrase (IN) catalyzing this process is of great interest as a target for new antiviral agents. We performed a structural-functional analysis of five different series of methylenebisphosphonates (BPs), PO3H2-C(R)(X)-PO3H2, as IN inhibitors with the goal of assessing structural elements required for the inhibitory activity. We found that IN is inhibited only by BP bearing a chlorobenzyl substituent R at the bridging carbon of the P-C-P backbone. These BP inhibited both IN-catalyzed reactions with similar efficacies. They were also active toward some INs with mutations characteristic for HIV-1 strains resistant to strand transfer inhibitors. The study of the mechanism of the IN inhibition by various BP showed that it is effected by the nature of the second substituent (X) at the bridging carbon. Among the tested compounds, only the BP with the amino group bound directly to the BP bridging carbon was found to be a noncompetitive inhibitor and, hence, it can be promising for further studies as potential inhibitor of the IN activity within the preintegration complex.


Sujet(s)
Diphosphonates/synthèse chimique , Inhibiteurs de l'intégrase du VIH/synthèse chimique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , Diphosphonates/composition chimique , Diphosphonates/pharmacologie , Conception de médicament , Résistance virale aux médicaments , Escherichia coli/génétique , Intégrase du VIH/génétique , Inhibiteurs de l'intégrase du VIH/composition chimique , Inhibiteurs de l'intégrase du VIH/pharmacologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Humains , Spectroscopie par résonance magnétique , Structure moléculaire , Spectrométrie de masse ESI , Relation structure-activité , Spécificité du substrat
17.
Biochimie ; 94(11): 2382-90, 2012 Nov.
Article de Anglais | MEDLINE | ID: mdl-22728110

RÉSUMÉ

Fluorometry using a substrate DNA labeled with a single fluorophore (6-carboxyfluorescein) at the 3'-end of the processed strand was shown to be a useful tool for monitoring DNA-binding and 3'-processing activities of HIV-1 and PFV integrases (INs). The DNA binding to either of the INs resulted in a fluorescence signal decrease, which is likely due to the fluorescence quenching by aromatic amino acids located near the 3'-end of the processed strand. The fluorescence deviations upon the 3'-processing strongly depended on the sequence of the fluorescein-labeled terminus of the substrate DNA. In the case of HIV-1 IN, a time-dependent fluorescence decrease was detected. Since it correlated with the rate of 3'-processing resulted in the labeled GT dinucleotide accumulation, it might be explained by the fluorescein quenching by a guanosine residue in the single-stranded dinucleotide. The 3'-processing catalyzed by PFV IN led to the fluorescence enhancement. We ascribed it to the migration of the cleaved AT dinucleotide conjugated with fluorescein away from the amino acids that could quench its fluorescence. The fluorescence-based assay was used for the search of new HIV-1 IN inhibitors. Some bisphosphonate derivatives, which are known to block the phosphorolytic activity of HIV-1 reverse transcriptase, were shown to inhibit HIV-1 IN at micromolar concentrations. This property makes bisphosphonates promising agents for the development of HIV-1 inhibitors affecting two viral enzymes.


Sujet(s)
ADN/composition chimique , ADN/métabolisme , Fluorimétrie/méthodes , Inhibiteurs de l'intégrase du VIH/pharmacologie , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Séquence nucléotidique , ADN/génétique , Évaluation préclinique de médicament , Hybridation d'acides nucléiques , Nucléotides/métabolisme , Oligodésoxyribonucléotides/composition chimique , Oligodésoxyribonucléotides/génétique , Oligodésoxyribonucléotides/métabolisme , Liaison aux protéines , Température
18.
Article de Anglais | MEDLINE | ID: mdl-21888554

RÉSUMÉ

Integration of the DNA copy of the genomic RNA into an infected cell genome is one of the key steps of the replication cycle of all retroviruses. It is catalyzed by the viral enzyme, integrase. We have shown that conjugates of short single-stranded oligonucleotides with eosin efficiently inhibit the catalytic activity of the HIV-1 integrase. In this article, we have found that the dependence of the integrase catalytic activity on the concentration of oligonucleotides has a bell-shaped pattern. The modulation of HIV-1 integrase activity correlated with the oligonucleotide length and was not associated with specific sequences. Moreover, a similar mode of the oligonucleotide action was found for integrase from the prototype foamy virus. This dual effect of the oligonucleotide and their conjugates with eosin might be explained by their binding with retroviral integrase in two different sites; the oligodeoxynucleotide binding in the first site results in integrase activation, whereas interactions with another one lead to inhibition of the enzyme activity. Eosin coupling to oligonucleotides did not change the mode of their action but enhanced their affinity to both binding sites. The affinity increase was found to be much more important for the site responsible for the integrase inhibition, thus explaining the high inhibitory potency of oligonucleotide-eosin conjugates.


Sujet(s)
Éosine jaunâtre/composition chimique , Éosine jaunâtre/pharmacologie , Inhibiteurs de l'intégrase du VIH/composition chimique , Inhibiteurs de l'intégrase du VIH/pharmacologie , Intégrase du VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Oligonucléotides/composition chimique , Oligonucléotides/pharmacologie , Infections à VIH/traitement médicamenteux , Infections à VIH/virologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , Humains
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE